The data in Figure 3 show that cure of both EMT6- and 4THM-injected mice of macroscopic and microscopic (DLN) tumor metastases following surgical resection and chemotherapy is resistant to anti-CD4 treatment, unlike mice cured of EMT6 tumor following surgery and immunotherapy. Here, CD4 is linked to neoplasm.